18742639. ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER (Board of Regents, The University of Texas System)
Contents
ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER
Organization Name
Board of Regents, The University of Texas System
Inventor(s)
Md Nurunnabi of El Paso TX (US)
Humayra Afrin of El Paso TX (US)
ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER
This abstract first appeared for US patent application 18742639 titled 'ORAL CODELIVERY OF 5-FLUOREURACIL AND Bcl2 siRNA TREATING STOMACH CANCER
Original Abstract Submitted
Compositions and methods are described for oral treatment of stomach cancer. A composition of matter for treatment of stomach cancer includes fluoreuracil-5; and Bcl2 siRNA. The composition can include β-glucan as a mucoadhesive nanocarrier.